ask="N/A"
ask_size="N/A"
average_daily_volume="464302"
bid="50.00"
bid_size="1500"
book_value="11.49"
change="+2.79"
change_from_200_day_moving_average="16.63"
change_from_50_day_moving_average="13.56"
change_from_52_week_high="-3.10"
change_From_52_week_low="41.73"
change_in_percent="+3.26%"
close="88.25"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-6.21"
ebitda="-244.58M"
eps_estimate_current_year="-7.11"
eps_estimate_next_quarter="-1.78"
eps_estimate_next_year="-6.45"
ex_dividend_date="N/A"
float_shares="38556000"
high="88.28"
high_52_weeks="91.35"
last_trade_date="3/3/2017"
last_trade_price="88.25"
last_trade_size="19663"
last_trade_time="4:00pm"
low="85.56"
low_52_weeks="46.52"
market_capitalization="3.68B"
moving_average_200_day="71.62"
moving_average_50_day="74.69"
name="Ultragenyx Pharmaceutical Inc."
notes="N/A"
one_year_target_price="93.71"
open="85.68"
pe_ratio="N/A"
peg_ratio="-0.42"
percent_change_from_200_day_moving_average="+23.22%"
percent_change_from_50_day_moving_average="+18.16%"
percent_change_from_52_week_high="-3.39%"
percent_change_from_52_week_low="+89.70%"
previous_close="85.46"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="7.44"
price_per_sales="26811.31"
revenue="133000.00"
shares_outstanding="41726000"
short_ratio="15.47"
stock_exchange="NMS"
symbol="RARE"
volume="412107"
weeks_range_52="46.52 - 91.35"
